Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rosing

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxelM M Malingré, D J Richel, J H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2008
Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometryR ter Heine, H Rosing, E C M van Gorp, et al.
Anti-Cancer Drugs|April 9, 1999
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic studyR van Gijn, W W ten Bokkel Huinink, S Rodenhuis, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2017
Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patientsL van Andel, H Rosing, Z Zhang, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
Investigational New Drugs|February 25, 2009
Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out miceJ H Beumer, N E Franke, R Tolboom, et al.
Journal of Mass Spectrometry : JMS|November 23, 2006
Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometryS A Veltkamp, M J X Hillebrand, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|November 29, 2017
Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patientsL van Andel, H Rosing, Z Zhang, et al.
British Journal of Cancer|January 5, 2001
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patientsM M Malingré, J H Beijnen, H Rosing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918C M F Kruijtzer, J H Beijnen, H Rosing, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxelM M Malingré, D J Richel, J H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2008
Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometryR ter Heine, H Rosing, E C M van Gorp, et al.
Anti-Cancer Drugs|April 9, 1999
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic studyR van Gijn, W W ten Bokkel Huinink, S Rodenhuis, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2017
Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patientsL van Andel, H Rosing, Z Zhang, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
Investigational New Drugs|February 25, 2009
Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out miceJ H Beumer, N E Franke, R Tolboom, et al.
Journal of Mass Spectrometry : JMS|November 23, 2006
Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometryS A Veltkamp, M J X Hillebrand, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|November 29, 2017
Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patientsL van Andel, H Rosing, Z Zhang, et al.
British Journal of Cancer|January 5, 2001
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patientsM M Malingré, J H Beijnen, H Rosing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918C M F Kruijtzer, J H Beijnen, H Rosing, et al.
Pageof 19